Streetbeat News

Regulatory

NRSN

NeuroSense Therapeutics has received a Notice of Allowance for its US patent application on compositions of Ciprofloxacin and Celecoxib for treating ALS and Alzheimer's Disease.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 2:20 pm

CSCO

HPE

JNPR

The European Commission will decide by August 1 on Hewlett Packard Enterprise's (HPE) $14 billion acquisition of Juniper Networks (JNPR). The deal aims to enhance HPE's AI offerings and expand its networking business. The UK competition authority is also reviewing the deal, with a decision expected by August 14. The acquisition is an all-cash transaction at $40.00 per share, a 32% premium over JNPR's stock price on January 8, 2024. Post-transaction, Juniper CEO Rami Rahim will lead the combined HPE networking business.

Portfolio Pulse from Nabaparna Bhattacharya

June 28, 2024 | 2:15 pm

RCKT

The FDA has issued a Complete Response Letter (CRL) to Rocket Pharmaceuticals' Biologics License Application for Kresladi, a gene therapy for severe leukocyte adhesion deficiency-I (LAD-I), requesting additional Chemistry Manufacturing and Controls (CMC) information. Despite positive Phase 1/2 study results, Rocket Pharmaceuticals' stock (NASDAQ:RCKT) fell by 9.01% following the news.

Portfolio Pulse from Vandana Singh

June 28, 2024 | 1:52 pm

BUD

TLRY

Tilray Brands (NASDAQ:TLRY) has been valued at $2 billion and is seen as having a $10 billion market opportunity. Analyst Pablo Zuanic has initiated coverage with a 'Neutral' rating, citing potential in global markets and U.S. federal legalization. Tilray's diversified portfolio includes beverages and wellness products, and it has invested in the U.S. market through debt holdings in MedMen. The company recently announced a $250 million equity offering to support its U.S. strategy. Despite challenges in the Canadian market, Tilray's international operations and strategic focus could significantly increase its market valuation.

Portfolio Pulse from Nicolás Jose Rodriguez

June 28, 2024 | 1:50 pm

PRGO

SPY

Iowa's highest court has allowed the state to enforce a ban on most abortions after about six weeks of pregnancy.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:43 pm

GOOG

GOOGL

Italy has demanded over $1 billion in unpaid taxes from Google, marking a new tax dispute following a similar case settled in 2017. The investigation spans from 2018 to 2022 and focuses on Google's digital infrastructure in Italy. This development adds to Google's ongoing regulatory challenges in Europe.

Portfolio Pulse from Benzinga Neuro

June 28, 2024 | 1:30 pm

REGN

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditional approval of odronextamab for relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma. The European Commission is expected to announce a final decision in the coming months. The positive opinion is based on Phase 1 and Phase 2 trials showing robust response rates and acceptable safety. Regeneron is also evaluating odronextamab in various other studies.

Portfolio Pulse from Vandana Singh

June 28, 2024 | 1:27 pm

CAPR

Capricor Therapeutics (NASDAQ:CAPR) announced positive 3-year safety and efficacy results from its HOPE-2 OLE study for deramiocel (CAP-1002) in treating Duchenne muscular dystrophy. The study showed benefits in both skeletal muscle and cardiac function, with a pre-BLA meeting with the FDA scheduled for Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:02 pm

WHLRD

Trading for WHLRD was halted and then resumed at 9:00:00 AM ET. The halt was due to news pending, and trading has now resumed.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:00 pm

SPY

In a CNBC interview, Fed's Daly stated that monetary policy is working but inflation remains too high. She aims to reduce inflation to 2% as gently as possible, expecting inflation to stay above 2% through 2025. Daly also mentioned that while generative AI could boost productivity, it's too early to speculate on its effects.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 12:59 pm